Follow
Oleksii Korzh / Корж Олексій
Oleksii Korzh / Корж Олексій
Харківський національний медичний університет
Verified email at knmu.edu.ua
Title
Cited by
Cited by
Year
Evolocumab and clinical outcomes in patients with cardiovascular disease
MS Sabatine, RP Giugliano, AC Keech, N Honarpour, SD Wiviott, ...
New England journal of medicine 376 (18), 1713-1722, 2017
56952017
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ...
New England journal of medicine 380 (24), 2295-2306, 2019
51232019
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
K Swedberg, M Komajda, M Böhm, JS Borer, I Ford, A Dubost-Brama, ...
The Lancet 376 (9744), 875-885, 2010
33492010
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ...
New England journal of medicine 369 (14), 1327-1335, 2013
31162013
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
K Fox, I Ford, PG Steg, M Tendera, R Ferrari
The Lancet 372 (9641), 807-816, 2008
14762008
Tiotropium versus salmeterol for the prevention of exacerbations of COPD
C Vogelmeier, B Hederer, T Glaab, H Schmidt, MPMH Rutten-van Mölken, ...
New England Journal of Medicine 364 (12), 1093-1103, 2011
9652011
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
F Zannad, CP Cannon, WC Cushman, GL Bakris, V Menon, AT Perez, ...
The Lancet 385 (9982), 2067-2076, 2015
8772015
Rivaroxaban for thromboprophylaxis in acutely ill medical patients
AT Cohen, TE Spiro, HR Büller, L Haskell, D Hu, R Hull, A Mebazaa, ...
New England Journal of Medicine 368 (6), 513-523, 2013
7372013
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
MR Weir, GL Bakris, DA Bushinsky, MR Mayo, D Garza, Y Stasiv, J Wittes, ...
New England Journal of Medicine 372 (3), 211-221, 2015
6872015
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ...
The Lancet 402 (10397), 203-234, 2023
6302023
Ivabradine in stable coronary artery disease without clinical heart failure
K Fox, I Ford, PG Steg, JC Tardif, M Tendera, R Ferrari
New England Journal of Medicine 371 (12), 1091-1099, 2014
6262014
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
KK Ray, B Molemans, WM Schoonen, P Giovas, S Bray, G Kiru, J Murphy, ...
European journal of preventive cardiology 28 (11), 1279-1289, 2021
5672021
Darapladib for preventing ischemic events in stable coronary heart disease
Stability Investigators
New England Journal of Medicine 370 (18), 1702-1711, 2014
5582014
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ...
New England Journal of Medicine 384 (2), 105-116, 2021
5482021
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24‐week, double‐blind, placebo‐controlled trial
K Strojek, KH Yoon, V Hruba, M Elze, AM Langkilde, S Parikh
Diabetes, Obesity and Metabolism 13 (10), 928-938, 2011
5342011
Tiotropium Respimat inhaler and the risk of death in COPD
RA Wise, A Anzueto, D Cotton, R Dahl, T Devins, B Disse, D Dusser, ...
New England Journal of Medicine 369 (16), 1491-1501, 2013
4682013
Эндотелиальная дисфункция при патологии сердечно-сосудистой системы
ЛТ Малая, АН Корж, ЛБ Балковая
Харьков: Торсинг 432, 2000
4542000
Triglyceride lowering with pemafibrate to reduce cardiovascular risk
A Das Pradhan, RJ Glynn, JC Fruchart, JG MacFadyen, ES Zaharris, ...
New England Journal of Medicine 387 (21), 1923-1934, 2022
3492022
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ...
The lancet respiratory medicine 7 (1), 46-59, 2019
2902019
Canagliflozin and cardiovascular and renal outcomes in type 2 diabetes mellitus and chronic kidney disease in primary and secondary cardiovascular prevention groups: results …
KW Mahaffey, MJ Jardine, S Bompoint, CP Cannon, B Neal, ...
Circulation 140 (9), 739-750, 2019
2662019
The system can't perform the operation now. Try again later.
Articles 1–20